As of 2026-03-30, 恒瑞医药's data on the DeepSeek platform in the 医疗保健 category shows: The overall mention rate is 0.00%, below the industry average by 1.7 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 恒瑞医药's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
恒瑞医药's Mention Rate is 0.00%, lower than 0.6% of competitors
恒瑞医药's First Mention is 0.00%, lower than 0.9% of competitors
恒瑞医药's Preferred Rate is 0.00%, lower than 100.0% of competitors
恒瑞医药's Positive Rate is 0.00%, lower than 8.9% of competitors
恒瑞医药's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 强强生 | 35.71% | 19.64% | 23.81% | 30.36% | 5.36% | View Details |
| 汤汤臣倍健 | 19.64% | 0% | 0% | 17.86% | 7.14% | View Details |
| 辉辉瑞 | 19.64% | 0% | 0% | 14.29% | 0% | View Details |
| 诺诺和诺德 | 19.64% | 0% | 0% | 12.5% | 5.36% | View Details |
| 罗罗氏 | 19.64% | 0% | 0% | 12.5% | 1.79% | View Details |
| 诺诺特兰德 | 16.07% | 5.36% | 0% | 14.29% | 8.93% | View Details |
| 恒恒瑞医药 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
